NCT05559047

Brief Summary

The study is designed to assess the usability of a novel CPAP human interface compared to a traditional nasal mask. Human subjects will interact with two different CPAP interfaces including a traditional CPAP mask and the 2nd generation DreamPort-Eclipse. Subjects will be requested to put on each of the different CPAP interface options a total of three times for a total of 6 trials. The order of device will be randomized.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 29, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

November 10, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 25, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 25, 2023

Completed
2.8 years until next milestone

Results Posted

Study results publicly available

November 10, 2025

Completed
Last Updated

November 10, 2025

Status Verified

October 1, 2025

Enrollment Period

3 months

First QC Date

September 26, 2022

Results QC Date

March 12, 2025

Last Update Submit

October 24, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Number of Participants Who Asked for Additional Information

    The total count of participants who asked for additional information during the course of home use of the mask was recorded

    Throughout the duration of the study (48 hours)

  • Mask Likeability

    A 16-item patient survey was administered to the participants at the end of the study. Patients had to answer according to a Likert scale (1: worst, 5:best). Here, this reflects the average of all the answered items. For example, question number one had an average score of 4.52, question number 2 had an average score of 4.21, etc. Since all questions reflect mask likability, they were averaged to provide an overall score.

    At 48 hours

  • Number of Participants Who Experienced Technical Issues

    Total count of participants who reported technical issues during the course of the 48 h home use of the mask were recorded

    The duration of the trial (48 h)

Study Arms (1)

In-House Usability Study Group

Seventy adherent CPAP users will volunteer to trial the Eclipse mask for two nights in their homes. Participants who attend an appointment at one of three offices of Sleep Centers of Middle Tennessee (SCMT) and will be trained how to use the Eclipse mask, then asked to use the Eclipse for two consecutive nights and then complete a participant survey after the second night. Participants will follow instructions to set up and put on the Eclipse nasal mask. They will fill out a survey about the ease and comfort of putting on and wearing the mask, briefly.

Device: Eclipse mask

Interventions

Users will interact with the Eclipse CPAP machine and report on usability/likeability.

In-House Usability Study Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults over the age of 18 who are CPAP users and attend SCAT centers who volunteer to be in the study.

You may qualify if:

  • Male or female ≥18 years old who are impacted by obstructive sleep apnea and currently are familiar with a CPAP device.

You may not qualify if:

  • Diagnosis of any medical or behavioral conditions that would compromise subject safety.
  • Under the age of 18: target for this current version of the platform is the adult population.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

AeroFlow Sleep

Asheville, North Carolina, 28803, United States

Location

Advanced Respiratory and Sleep Medicine

Huntersville, North Carolina, 98078, United States

Location

Sleep Centers of Middle Tennessee

Murfreesboro, Tennessee, 37129, United States

Location

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Results Point of Contact

Title
Stuart Heatherington
Organization
Bleep, LLC

Study Officials

  • Stuart Heatherington

    Bleep, LLC

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2022

First Posted

September 29, 2022

Study Start

November 10, 2022

Primary Completion

January 25, 2023

Study Completion

January 25, 2023

Last Updated

November 10, 2025

Results First Posted

November 10, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Data collected through surveys will be available upon request to the principal investigator. Data requested will be de-identified. Only de-identified data will be made available. Only survey responses and the investigators' observational notes, also deidentified, will be shared. No PHI will be shared. Aggregated participant demographic data will be shared.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Data will become available 4 years after the study completion.
Access Criteria
Requests will be made in writing, to the PI, at stuart@bleepsleep.com. Requests should include the reason for the request, how the data is intended to be used, and additional information may be requested. Data will be shared with credentialed, licensed, or otherwise verifiable researchers/investigators for research purposes only.

Locations